Abnormal distribution of fat tissue and its association with intestinal failure-associated liver disease in children and adolescents with long-time parenteral nutrition support: A case-control study

JPEN J Parenter Enteral Nutr. 2023 Sep;47(7):938-946. doi: 10.1002/jpen.2548. Epub 2023 Jul 21.

Abstract

Background: Patients with intestinal failure (IF) often present with abnormal body composition characterized by high fat mass. However, the distribution of fat and its association with the development of IF-associated liver disease (IFALD) remain unclear. This study aims to investigate the body composition and its relationship with IFALD in older children and adolescents with IF.

Methods: This retrospective case-control study enrolled patients with IF receiving parenteral nutrition (PN) at Keio University Hospital who initiated PN before the age of 20 years (cases). The control group included patients with abdominal pain, with available computed tomography (CT) scan and anthropometric data. CT scan images of the third lumbar vertebra (L3) were used for body composition analysis and compared between the groups. Liver histology was compared with CT scan findings in IF patients who underwent biopsy.

Results: Nineteen IF patients and 124 control patients were included. To account for age distribution, 51 control patients were selected. The median skeletal muscle index was 33.9 (29.1-37.3) in the IF group and 42.1 (39.1-45.7) in the control group (P < 0.01). The median visceral adipose tissue index (VATI) was 9.6 (4.9-21.0) in the IF group and 4.6 (3.0-8.3) in the control group (P = 0.018). Among the 13 patients with IF who underwent liver biopsies, 11 (84.6%) had steatosis, and there was a tendency for fibrosis to correlate with VATI.

Conclusion: Patients with IF exhibit low skeletal muscle mass and high visceral fat, which may be related to liver fibrosis. Routine monitoring of body composition is recommended.

Keywords: body composition; intestinal failure; intestinal failure-associated liver disease; nonalcoholic fatty liver disease; steatosis.

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • Child
  • Humans
  • Intestinal Diseases* / therapy
  • Intestinal Failure*
  • Liver Diseases* / complications
  • Liver Failure* / complications
  • Parenteral Nutrition
  • Retrospective Studies
  • Young Adult